The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy) | Image Credit: US Food and Drug Administration
FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy)

February 21st 2025

The US supply of semaglutide and semaglutide 2.4 mg now meets or exceeds current and projected demand, ending the long-running shortages of these blockbuster drugs.

Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD | Image Credit: Mount Sinai
Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD

February 18th 2025

CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes | Image Credit: LinkedIn
CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes

February 11th 2025

Age May Modify Cardioprotective Effects of SGLT2 Inhibitors, GLP-1 RAs | Image Credit: Danie Franco/Unsplash
Age May Modify Cardioprotective Effects of SGLT2 Inhibitors, GLP-1 RAs

February 6th 2025

Novo Nordisk | Credit: Novo Nordisk
Monlunabant Misses Primary Endpoint in Phase 2 Diabetic Kidney Disease Trial

February 5th 2025

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.